June 1, 2022
Abbott’s FreeStyle Libre 3 Cleared for U.S.
May 5, 2022
Abbott's Strong Growth and Pipeline
February 3, 2022
Abbott's Powerful Start to 2022
December 15, 2021
Abbott is Keynoting CES: The Countdown is On
Abbott is Making Health Tech History
Abbott is Building a Sustainable Future
Abbott Innovation Goes Next Level
Abbott's Impressive Start to 2021
Delivering Long-Term Impact
COVID Testing, Inspiring the Future
Abbott Levels Up Its FreeStyle Tech
Abbott is Changing the Game in COVID Testing
Abbott Rises to the Test
Abbott's Strong Start to 2020
Developments in Connected Care
Abbott's Calling on Companies to Join the STEM Movement
Great Momentum for Abbott
New Developments in Heart and Brain Health
March 25, 2019
Late-Breaking Data, Product Approvals, Partnerships and More
February 5, 2019
Abbott's Bold Leap into 2019
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.